Skip to main content
Home

Main navigation

  • Our Company
    • Who we are
    • Senior Leadership Team
    • Board of Directors
    • Sustainability
    • Awards and Recognition
    • Virtual Company Tour
  • Our Solutions
    • AGROBODY Foundry™
    • Product pipeline
    • Evoca™
    • Field trials
  • Investors
    • Press releases
    • Financial information
    • Stock Information
    • Shareholder information
    • Corporate governance
    • Events
    • Presentations
    • IPO
  • Partnering
  • News & Events
    • Press releases
    • Events
    • Stay in touch
    • Message from our CEO
  • Careers
    • Open Positions
    • Vision & Values
    • What our employees say
    • Benefits and wellbeing
  • Contact

User account menu

  • Log in

Press releases

Go back to Investors overview
June 29, 2021

Biotalys Announces Coverage of the Base Offering Throughout the Price Range of its Initial Public Offering on Euronext Brussels

June 29, 2021

Biotalys Announces Coverage of the Base Offering Throughout the Price Range

PDF icon
EN
PDF icon
FR
PDF icon
NL
June 23, 2021

Biotalys launches its Initial Public Offering on Euronext Brussels

June 23, 2021

Biotalys launches its Initial Public Offering on Euronext Brussels

PDF icon
EN
PDF icon
FR
PDF icon
NL
June 17, 2021

Biotalys’ ongoing trial program demonstrates strong potential of its new generation protein-based biocontrols

PDF icon
EN
June 15, 2021

Biotalys announces Intention to Launch an Initial Public Offering on Euronext Brussels

PDF icon
EN
PDF icon
FR
PDF icon
NL
June 15, 2021

Biotalys announces Intention to Launch an Initial Public Offering on Euronext Brussels

June 10, 2021

Biotalys Nominates Catherine Moukheibir to its Board of Directors

May 4, 2021

Biotalys Earns Recognition in Fast Company’s 2021 World Changing Ideas Awards

April 20, 2021

Biotalys Appoints Simon Moroney as Chairman of the Board

March 25, 2021

Biotalys Files its First Protein-Based Biocontrol for Registration in the EU

January 21, 2021

Biotalys Submits First Protein-Based Biocontrol Registration Package to the EPA

October 1, 2020

Biotalys awarded €1.1 million VLAIO research grant

September 10, 2020

Biotalys Honored with Two AgTech Breakthrough Awards

July 9, 2020

Biotalys appoints Wim Ottevaere as Chief Financial Officer in preparation for global growth

Pagination

  • Previous page <
  • …
  • Page 8
  • Current page 9
  • Page 10
  • Next page >

Social Menu

  • Twitter
  • LinkedIn
  • Email

Footer navigation (primary)

  • Our Company
    • Who we are
    • Senior Leadership Team
    • Board of Directors
  • Our Solutions
    • AGROBODY Foundry™
    • Product pipeline
  • Investors

Footer navigation (secondary)

  • Partnering
  • Media
    • Press releases
    • Events
    • Download section
    • Stay in touch
  • Contact

Home

Biotalys NV
Buchtenstraat 11
Ghent 9051, Belgium
Phone: +32 (0)9 274 5400

info@biotalys.com

© Copyright 2026 Biotalys NV | Privacy Policy | General Purchasing Conditions